Thijs Cohen Tervaert – Startup Investor Profile

General Info

Thijs Cohen Tervaert is a Director at INKEF Capital with a focus on Healthcare and ICT/New Media/FinTech. He has been involved in investments like TargED Biopharmaceuticals. INKEF Capital prefers to invest in the Netherlands, aiming for target equity checks of USD 15-50 million. Their collaboration style focuses on cooperative collaboration, competitive collaboration, directive collaboration, facilitative collaboration, and delegative collaboration.
Location: Amsterdam, Netherlands
Country: Netherlands
Industries:
Investment Regions: EU
Investment Stages: pre-seed, seed

angel-individual
EU

Want to start building warm intros with this investor?

Get Started for Free

🤖 AI Activity Report

Status: low-active

AI Reasoning: Search results show Thijs Cohen Tervaert involved in TargED Biopharmaceuticals Series A announced Feb 22, 2022. The most recent relevant documents (Crunchbase, PRs) list that Series A or board involvement in 2022 and no subsequent investments found through searches including a 2025 TargED press release which did not list new investments by him. From Feb 22, 2022 to Nov 1, 2025 is more than 12 months (over 3 years), so the correct classification is low-active.

Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.



Access all contact details of Thijs Cohen Tervaert

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.

Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.

Trusted by Founders like You

Find your matching investors using AI

Sign up to EasyVC